Sandbox: Syncope

Revision as of 00:26, 30 October 2017 by Arzu Kalayci (talk | contribs) (Created page with "==2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope== ===Recommendation for History and Physical Examination=== {| class="wikitable" styl...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Recommendation for History and Physical Examination

COR LOE RECOMMENDATION
I B-NR A detailed history and physical examination should be performed in patients with syncope.
I B-NR In the initial evaluation of patients with syncope, a resting 12-lead electrocardiogram (ECG) is useful.
I B-NR Evaluation of the cause and assessment for the short- and long-term morbidity and mortality risk of syncope are recommended.
IIb B-NR Use of risk stratification scores may be reasonable in the management of patients with syncope.
Recommendations for Disposition After Initial Evaluation.
I B-NR Hospital evaluation and treatment are recommended for patients presenting with syncope who have a serious medical condition potentially relevant to the cause of syncope identified during initial evaluation.
IIa C-LD It is reasonable to manage patients with presumptive reflex-mediated syncope in the outpatient setting in the absence of serious medical conditions.

|- | bgcolor="LemonChiffon" | IIa || bgcolor="LightBlue" | B-R || In intermediate-risk patients with an unclear cause of syncope, use of a structured ED observation protocol can be effective in reducing hospital admission. |- | bgcolor="LemonChiffon" | IIb || bgcolor="LightBlue" | C-LD || It may be reasonable to manage selected patients with suspected cardiac syncope in the outpatient setting in the absence of serious medical conditions. |- | Recommendations for Blood Testing || || |- | bgcolor="LemonChiffon" | IIa || bgcolor="LightBlue" | B-NR || Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG. |- | bgcolor="LemonChiffon" | IIb || bgcolor="LightBlue" | C-LD || Usefulness of brain natriuretic peptide and high-sensitivity troponin measurement is uncertain in patients for whom a cardiac cause of syncope is suspected. |- | bgcolor="LightCoral" | III No Benefit || bgcolor="LightBlue" | B-NR || Targeted blood tests are reasonable in the evaluation of selected patients with syncope identified on the basis of clinical assessment from history, physical examination, and ECG.